Navigation Links
Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage
Date:7/6/2011

On July 8, at approximately 11:26 a.m. EDT, the space shuttle Atlantis will streak skyward from the Kennedy Space Center's launch pad 39A, for one last mission. While the STS-135 flight marks the end of the space shuttle's glory days, its final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Dr's. Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State University's Biodesign Institute.

Nickerson, a microbiologist and authority on infectious pathogens, has been using spaceflight or spaceflight analogues since 1998 as an exploratory platform for investigating the processes of infection. Her provocative approach to microbial research has already paid rich dividends. In earlier experimental missions, Nickerson's team demonstrated that conditions of microgravity present aboard the space shuttle have the potential to increase the disease-causing capacity or virulence of microbes like Salmonellaa major causative agent of food-borne illness.

Further, her research demonstrated that spaceflight globally altered gene expression in Salmonella and other pathogens in critical ways that were not observed during culture on Earth, and were governed by a master switch regulating this response. "Our earlier work showed the potential for spaceflight to provide novel insight into the mechanisms of microbial virulence that may lead to innovations in infectious disease control here on Earth," she said.

Curtiss, director of the Biodesign Institute's Center for Infectious Diseases and Vaccinology, has engineered an experimental vaccine strain, which will fly aboard Atlantis on its journey to the International Space Station Laboratory. By removing the disease-causing components of Salmonella and incorporating a key protective antigen from Streptococcus pneumoniae, Curtiss has produced a powerful oral vaccine against pneumonia, that ha
'/>"/>

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. SCOLR Pharma, Inc. Announces Final Closing of Private Placement
2. Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study
3. TEI Biosciences Chairman, President and CEO Yiannis Monovoukas Named Ernst & Young Entrepreneur Of The Year® 2011 New England Award Semifinalist
4. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
5. Helix BioPharma Completes Definitive GLP Toxicology Studies With L-DOS47 and is Making Final Preparations for its Planned Phase I/II Clinical Study IND/CTA Submissions
6. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
7. Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010
8. Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community
9. ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California
10. ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data
11. Profil Institutes Dr. Marcus Hompesch Named Finalist in Ernst & Young Entrepreneur Of The Year(R) 2010 Award for Second Year in a Row
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage
(Date:7/10/2014)... Mass. (PRWEB) July 10, 2014 Terascala, ... today announced that Alan Swahn, a former vice president ... executive team as vice president of marketing. Terascala’s software ... Dell and NetApp create the highest performance and most ... been appointed to guide Terascala’s channel expansion and broaden ...
(Date:7/10/2014)... July 10, 2014 Robert Harman, DVM, Founder ... company, is proud to announce the relaunch of his highly ... a new series called “ What are Stem Cells ?” ... honest and straightforward foundation in the basics of stem cell ... on the right type of treatment when considering regenerative medicine. ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been upgraded ... with a second treatment cup to help prevent and smooth ... is thinner on the edges for a softer contact with ... uneven surfaces on the face, neck and décolleté. Choose to ... areas such as the cheeks and neck, or opt for ...
(Date:7/10/2014)... POINT, Ind. , July 10, 2014 ... expanded its use of capnography for respiratory ... growing group of healthcare leaders in embracing ... measures how effectively patients are breathing and ... depression occurs. By measuring the amount of ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... 2011 Halozyme Therapeutics, Inc. (NASDAQ: ... products targeting the extracellular matrix for the ... financial results for the third quarter of 2011 and ... ) "The past few months highlight the ...
... 2011 BIOCOM, the trade group representing Southern California,s ... partnered to tell the biotechnology story from discovery through ... glimpse into the exciting and innovative world of medical ... to patients around the globe. "Tomorrow,s Health," a new ...
... 2011 Note: numbers in square brackets relate ... available for interview. Investment fund manager Porton Group ... a court battle with 3M over the multi-national company,s failure ... The High Court in London found 3M was "in material ...
Cached Biology Technology:Halozyme Therapeutics Reports Third Quarter 2011 Financial Results 2Halozyme Therapeutics Reports Third Quarter 2011 Financial Results 3Halozyme Therapeutics Reports Third Quarter 2011 Financial Results 4Halozyme Therapeutics Reports Third Quarter 2011 Financial Results 5Halozyme Therapeutics Reports Third Quarter 2011 Financial Results 6Halozyme Therapeutics Reports Third Quarter 2011 Financial Results 73M Forced to Pay for Breach of Obligations Over MRSA - High Court 23M Forced to Pay for Breach of Obligations Over MRSA - High Court 33M Forced to Pay for Breach of Obligations Over MRSA - High Court 4
(Date:7/10/2014)... Channel has resulted in the removal of many top ... barrel, for increasing amounts of shellfish to make up ... species at the head of the food chain are ... completely., These are some of the findings of a ... association with international non-profit research organization WorldFish. They analysed ...
(Date:7/10/2014)... start-up company housed at NJIT,s business incubator, received a ... that surgeons will use to staunch bleeding during brain ... surgical site, and the natural bio-polymer solutions in the ... within 30 seconds. , The gel can shorten ... translate into less time for the patient,s skull to ...
(Date:7/10/2014)... today that Courtney Aldrich, Ph.D., will head the ... as editor-in-chief. With the first issue slated for ... meet a growing demand for a place to ... vision is to develop a journal focused on ... science that advances the field and lays the ...
Breaking Biology News(10 mins):Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 2Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 3A start-up at NJIT develops bleeding-control gel for brain surgery 2ACS Infectious Diseases: Unique chemistry journal names editor 2
... not only supplies key nutrients, it may also influence hormone ... a new study led by researchers at the University of ... diet in human evolution. The research is the ... phytoestrogens, and behavior in wild primates in this case, ...
... 19, 2012 Deciphering what causes the brain cell degeneration ... But a team led by scientists from The Scripps Research ... brain cells in a mouse model of Parkinson,s disease. The ... be useful in preventing the actual condition. The team, ...
... MD, MPH, has been named the winner of the $100,000 ... 6,500 online votes from people across the globe determined the ... sequencing of newborns, emerged as the winner after six weeks ... for creating this competition and I am delighted to win. ...
Cached Biology News:Estrogenic plants linked to altered hormones, possible behavior changes in monkeys 2Estrogenic plants linked to altered hormones, possible behavior changes in monkeys 3Scripps Research Institute team identifies a potential cause of Parkinson's disease 2Scripps Research Institute team identifies a potential cause of Parkinson's disease 3Research gets real - Public votes determine winner of $100,000 research prize 2
HyPro 20 system for slide hybridization. 20 slide capacity. Active vibration system, slide rack and humidity chamber. Ideal for microarray and in situ hybridization....
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
Request Info...
Request Info...
Biology Products: